KP Tissue Inc (TSE:KPT) had its target price reduced by equities researchers at National Bank Financial from C$17.00 to C$15.50 in a report issued on Thursday. The firm currently has a “sector perform” rating on the stock. National Bank Financial’s price objective indicates a potential upside of 10.16% from the company’s previous close. National Bank Financial also issued estimates for KP Tissue’s FY2017 earnings at $0.84 EPS and FY2019 earnings at $1.26 EPS.
Other analysts have also recently issued reports about the company. TD Securities upgraded KP Tissue from a “hold” rating to a “buy” rating and set a C$16.00 target price for the company in a report on Thursday, August 10th. Scotiabank dropped their target price on KP Tissue from C$18.00 to C$17.50 and set an “outperform” rating for the company in a report on Thursday, August 10th.
Shares of KP Tissue (KPT) opened at C$14.07 on Thursday. KP Tissue has a twelve month low of C$13.31 and a twelve month high of C$16.34.
TRADEMARK VIOLATION NOTICE: This story was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://stocknewstimes.com/2017/11/11/kp-tissue-inc-kpt-price-target-cut-to-c15-50.html.
About KP Tissue
KP Tissue Inc is a Canada-based company, created to acquire, and its business is limited to holding, a limited partnership interest in Kruger Products L.P. (KPLP). KPLP is a tissue products supplier, which produces, distributes, markets and sells bathroom and facial tissue, paper towels and napkins, for both the Consumer and the Away-From-Home (AFH) markets.
Receive News & Ratings for KP Tissue Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue Inc and related companies with MarketBeat.com's FREE daily email newsletter.